Abbott Laboratories (Pakistan) (KAR:ABOT) Cyclically Adjusted FCF per Share: ₨28.49 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KAR:ABOT Abbott Laboratories (Pakistan) Ltd KAR:ABOT
73 GF Score
Price ₨940.73
GF Value ₨1,015.73
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Abbott Laboratories (Pakistan) Cyclically Adjusted FCF per Share?

Abbott Laboratories (Pakistan) KAR:ABOT +0.52% 73 Cyclically Adjusted FCF per Share is ₨28.49 as of Jun. 2026. GuruFocus rates KAR:ABOT with a GF Score™ of 73/100 and a GF Value™ of ₨1,015.73 (Fairly Valued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Abbott Laboratories (Pakistan)'s adjusted free cash flow per share for the three months ended in Jun. 2026 was ₨6.010. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ₨28.49 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Abbott Laboratories (Pakistan)'s average Cyclically Adjusted FCF Growth Rate was 16.60% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -1.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Abbott Laboratories (Pakistan) was -1.40% per year. The lowest was -1.40% per year. And the median was -1.40% per year.

As of today (2026-09-07), Abbott Laboratories (Pakistan)'s current stock price is ₨940.73. Abbott Laboratories (Pakistan)'s Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was ₨28.49. Abbott Laboratories (Pakistan)'s Cyclically Adjusted Price-to-FCF of today is 33.02.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Abbott Laboratories (Pakistan) was 53.09. The lowest was 11.74. And the median was 29.68.


Abbott Laboratories (Pakistan)  (KAR:ABOT) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Abbott Laboratories (Pakistan)'s Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=940.73/28.49
=33.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Abbott Laboratories (Pakistan) was 53.09. The lowest was 11.74. And the median was 29.68.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Abbott Laboratories (Pakistan) Cyclically Adjusted FCF per Share Related Terms


Abbott Laboratories (Pakistan) Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Abbott Laboratories (Pakistan)'s Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott Laboratories (Pakistan) Cyclically Adjusted FCF per Share Chart

Abbott Laboratories (Pakistan) Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 29.68 25.38 24.15 28.41

Abbott Laboratories (Pakistan) Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.44 24.98 28.41 27.69 28.49

KAR:ABOT vs ZTS, UTHR: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Abbott Laboratories (Pakistan)'s Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott Laboratories (Pakistan) Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abbott Laboratories (Pakistan)'s Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories (Pakistan)'s Cyclically Adjusted Price-to-FCF falls into.


KAR:ABOT
73GF Score
Abbott Laboratories (Pakistan) Ltd KAR:ABOT
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abbott Laboratories (Pakistan) Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Abbott Laboratories (Pakistan)'s adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=6.01/333.9520*333.9520
=6.010

Current CPI (Jun. 2026) = 333.9520.

Abbott Laboratories (Pakistan) Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 9.199 241.428 12.724
201612 10.312 241.432 14.264
201703 1.030 243.801 1.411
201706 18.775 244.955 25.596
201709 7.412 246.819 10.029
201712 15.273 246.524 20.689
201803 2.487 249.554 3.328
201806 -9.265 251.989 -12.279
201809 5.760 252.439 7.620
201812 7.067 251.233 9.394
201903 -16.615 254.202 -21.828
201906 0.246 256.143 0.321
201909 -13.041 256.759 -16.962
201912 8.052 256.974 10.464
202003 15.157 258.115 19.610
202006 17.581 257.797 22.775
202009 12.969 260.280 16.640
202012 23.336 260.474 29.919
202103 19.035 264.877 23.999
202106 26.066 271.696 32.039
202109 4.298 274.310 5.232
202112 9.465 278.802 11.337
202203 6.090 287.504 7.074
202206 -0.990 296.311 -1.116
202209 -16.542 296.808 -18.612
202212 13.609 296.797 15.313
202303 -18.542 301.836 -20.515
202306 -35.493 305.109 -38.848
202309 -2.368 307.789 -2.569
202312 24.247 306.746 26.398
202403 -7.384 312.332 -7.895
202406 0.421 314.175 0.448
202409 2.449 315.301 2.594
202412 21.390 315.605 22.633
202503 1.615 319.799 1.686
202506 13.133 322.561 13.597
202509 17.446 324.800 17.938
202512 43.812 324.054 45.150
202603 -10.566 330.213 -10.686
202606 6.010 333.952 6.010

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of ₨28.49 mean?
Abbott Laboratories (Pakistan) (KAR:ABOT) has a Cyclically Adjusted FCF per Share of ₨28.49 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Abbott Laboratories (Pakistan) and its competitors.
Is Abbott Laboratories (Pakistan)'s Cyclically Adjusted FCF per Share too high?
Abbott Laboratories (Pakistan)'s current Cyclically Adjusted FCF per Share is ₨28.49. Overall, Abbott Laboratories (Pakistan) has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories (Pakistan)'s Cyclically Adjusted FCF per Share compare to ZTS and UTHR?
Abbott Laboratories (Pakistan)'s Cyclically Adjusted FCF per Share of ₨28.49 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Abbott Laboratories (Pakistan) and its competitors. Abbott Laboratories (Pakistan)'s current Cyclically Adjusted FCF per Share is ₨28.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories (Pakistan) stock overvalued right now?
Based on GuruFocus' analysis, Abbott Laboratories (Pakistan) (KAR:ABOT) is currently considered Fairly Valued. The stock's GF Value™ is ₨1,015.73, compared to a current price of ₨940.73 — trading 7.4% below its estimated fair value. The current Cyclically Adjusted FCF per Share is ₨28.49. Abbott Laboratories (Pakistan)'s overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Abbott Laboratories (Pakistan) (KAR:ABOT), the current Cyclically Adjusted FCF per Share is ₨28.49 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abbott Laboratories (Pakistan) (KAR:ABOT) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott Laboratories (Pakistan) stock appears to be undervalued. The current stock price of ₨940.73 is trading 7.4% below its estimated GF Value™ of ₨1,015.73. GuruFocus considers Abbott Laboratories (Pakistan) to be Fairly Valued.

Key valuation signals for KAR:ABOT:

  • Cyclically Adjusted FCF per Share: ₨28.49
  • GF Value™: ₨1,015.73 vs. price of ₨940.73 (7.4% below fair value)
  • GF Score™: 73/100 with 3 warning signs

No single metric tells the full story. See the KAR:ABOT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Abbott Laboratories (Pakistan) Business Description

Address Hyderabad Road, Landhi, P.O. Box 7229, Plot No. 258 & 324, Opposite Radio Pakistan Transmission Centre, Karachi, PAK, 75120
Abbott Laboratories (Pakistan) Ltd manufactures, imports, and markets research-based pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products. Its operating segments are Pharmaceutical, Nutritional, Diagnostics, and Others. It generates maximum revenue from the Pharmaceutical segment. Geographically, it derives the majority of its revenue from Pakistan and has a presence in Afghanistan, Sri Lanka, Bangladesh, and Switzerland. The company's Brands include Duphaston, Brufen, Surbex Z, Arinac, Glucerna, Pediasure, and Ensure.
73GF Score

Get the complete analysis for KAR:ABOT

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₨940.73
Price
₨1,015.73
GF Value